Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
16°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neumora Therapeutics, Inc. - Common Stock
(NQ:
NMRA
)
9.690
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
250
Open
9.690
Bid (Size)
9.200 (9)
Ask (Size)
10.13 (1)
Prev. Close
9.690
Today's Range
9.690 - 9.690
52wk Range
8.330 - 21.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 12, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Performance
YTD
-42.66%
-42.66%
1 Month
-30.59%
-30.59%
3 Month
-15.74%
-15.74%
6 Month
+4.08%
+4.08%
1 Year
-18.64%
-18.64%
More News
Read More
Neumora Therapeutics to Participate in Upcoming Conferences in November
November 06, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
November 05, 2024
Via
Benzinga
Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
October 29, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
October 21, 2024
Via
Benzinga
Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders
August 14, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
NMRA Stock Earnings: Neumora Therapeutics Meets EPS for Q2 2024
August 06, 2024
Via
InvestorPlace
Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
August 06, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation
June 20, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
May 14, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
NMRA Stock Earnings: Neumora Therapeutics Meets EPS for Q1 2024
May 07, 2024
Via
InvestorPlace
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
May 07, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Neumora Therapeutics to Participate in Upcoming Conferences in May
May 06, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March
April 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crude Oil Down 1%; Charles Schwab Sales Top Estimates
April 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday?
April 15, 2024
Via
Benzinga
Exposures
Product Safety
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 15, 2024
Via
Benzinga
Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug
April 15, 2024
Via
Investor's Business Daily
Why Is Mobile Global Esports (MGAM) Stock Down 18% Today?
April 15, 2024
Via
InvestorPlace
Why Is Neumora Therapeutics (NMRA) Stock Down 25% Today?
April 15, 2024
Via
InvestorPlace
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
April 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 15, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 15, 2024
Via
InvestorPlace
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
April 15, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.